0 results available. Select is focused ,type to refine list, press Down to open the menu,
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...
The following section summarizes insights on Novartis AG's Return on Invested Capital:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Return on Invested Capital in the efficiency category include:
A capital efficiency ratio used to measure a firm's ability to create value for all its stakeholders, debt, and equity.
Return on Invested Capital or ROIC is defined as:
Net Operating Profit After Tax
(/) Average Invested Capital
Return on Invested Capital
Return on Invested Capital for Novartis is calculated as follows:
Net Operating Profit After Tax [ $14.362 B ]
(/) Average Invested Capital over Period [ $74.358 B ]
(=) Return on Invested Capital [ 19.3% ]
Where Invested Capital is calculated as follows:
(+) Average debt = ($26.439 B + $31.401 B) / 2 = $28.92 B
(+) Average Equity = ($46.75 B + $44.126 B) / 2 = $45.438 B
(=) Invested Capital [ $74.358 B ]
The tables below summarizes the trend in Novartis’s return on assets over the last five years:
| Fiscal Year | Net Operating Profit After Tax | Average Invested Capital | Return on Invested Capital |
|---|---|---|---|
| 2020-12-31 | $8.934 B | $89.799 B | 9.9% |
| 2021-12-31 | $9.647 B | $96.815 B | 10.0% |
| 2022-12-31 | $8.107 B | $93.151 B | 8.7% |
| 2023-12-31 | $11.125 B | $80.288 B | 13.9% |
| 2024-12-31 | $14.362 B | $74.358 B | 19.3% |
Return on Invested Capital is used to evaluate the ability of the company to create value for all its stakeholders, debt and equity. ROIC can be used to benchmark companies within an industry but it is also useful to consider its relationship to the Weighted Average Cost of Capital (WACC).
Since ROIC measures the company’s ability to generate a return on invested capital, and the WACC measures the minimum return required by the company’s capital providers (equity and debt), the difference between ROIC and WACC is referred to as Economic Profit or Excess Return.
Excess Return = Return on Invested Capital - Weighted Average Cost of Capital
The chart above depicts the distribution of return on invested capital for companies operating in the Healthcare sector in the Developed economic region. Over 1,890 companies were considered in this analysis, and 1,820 had meaningful values. The average return on invested capital of companies in the sector is -28.9% with a standard deviation of 43.3%.
Novartis AG's Return on Invested Capital of 19.3% ranks in the 97.7% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,896 |
| Included Constituents | 1,820 |
| Min | -198.1% |
| Max | 23.7% |
| Median | -16.7% |
| Mean | -28.9% |
| Standard Deviation | 43.3% |
You can find companies with similar return on invested capital using this stock screener.